Amie J Goodin, Ph.D.
Assistant Professor
About Amie J Goodin
Dr. Goodin is an Assistant Professor within the Department of Pharmaceutical Outcomes and Policy (POP) and the Center for Drug Evaluation and Safety (CoDES). She received her Master of Public Policy degree from the University of Kentucky (UK). She completed her Doctor of Philosophy degree at UK’s Martin School of Public Policy, with specialization in pharmaceutical outcomes and an additional Certificate in Informatics. She completed a Postdoctoral Fellowship at University of Florida POP, specializing in pharmacoepidemiology methods while continuing her work in Health Services Research. She is the lead for Health Services Research track within POP’s graduate program as well as the faculty lead for Research Strategy within the Consortium for Medical Marijuana Clinical Outcomes Research. Currently, her research projects incorporate mixed-method approaches to assess the impact of policy changes related to treatment access and utilization for Substance Use Disorders, particularly among persons enrolled in Medicaid and pregnant women.
Teaching Profile
Research Profile
- Health Policy
- Health disparities and vulnerable populations
- Maternal and Child Health
- Substance Use Disorders
- health services research
0000-0002-0020-8720
Publications
Grants
Education
Contact Details
- Business:
- (352) 294-8829
- Business:
- amie.goodin@ufl.edu
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
HPNP 3319
GAINESVILLE FL 326103007
Recent news
New Florida law leads to decline in opioid use, according to UF study
UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.
UF Health researchers develop CMS quality measure to evaluate inpatient psychiatric hospitals
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
Dr. Amie Goodin featured in NY Times story on the opioid crisis
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
We Cannot Treat the Dead
Assistant Scientist Amie Goodin, Ph.D., publishes an editorial in the American Journal of Public Health on the opioid epidemic.